Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5, also known as CEA or CD66e) was firstly reported as a tumor marker for colorectal cancer in 1965 (20). This evidence concerns the gene CEACAM5 and neoplasm.